drug
urcosimod
Phase 2updated 3mo agoby $OKYO OKYO Pharma Ltd
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- OKYO Pharma Announces Purchase of Shares by Chief Scientific OfficerLONDON and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur…globenewswire_health · 13d ago
Data sources
last refreshed 50m ago
Found something off?
comments(0)
5-min edit window · permanent after that